New York, NY -- (SBWIRE) -- 08/24/2020 -- The major reasons the global defibrillator market is advancing are the increasing geriatric population and cardiac disease prevalence, technological advancements in these products, and strategic developments among the companies offering these medical devices. P&S Intelligence has made the following key observations regarding the industry:

- Sale of defibrillators will generate revenue of $20,281.6 million by 2030
- Market will grow at a CAGR of 7.2% between 2020 and 2030

Pre-hospital care settings; hospitals, clinics, & cardiac centers; home care settings, and public-access settings are the categories under the end user segment. Among these, the hospitals, clinics, & cardiac centers category held the largest share in the defibrillator market during 2014–2019 (historical period), owing to the rapid procurement of improved products in such settings, for better patient outcomes and cost efficiency. This is also the reason this category will continue dominating the industry throughout the next decade.

Request to view sample of this market research at: https://www.psmarketresearch.com/market-analysis/defibrillator-market-forecast/report-sample

The defibrillator market is bifurcated into external defibrillators and implantable cardioverter defibrillators (ICD), under segmentation by type, of which the ICD bifurcation is expected to generate the higher revenue in the years to come. This is because these products monitor the heart rate, treat tachycardias (fast heart rate), and restore the normal sinus rhythm. With the enhancements in their technology, the demand for them is predicted to keep rising in the years to come.

The objective of this research includes;

- Major factors driving the defibrillators market and their impact during the short, medium, and long terms
- Market restraints and their impact during the short, medium, and long terms
- Recent trends and evolving opportunities for the defibrillators market participants
- Historical and the present size of the market segments and understand their comparative future potential
- Potential of on-demand logistics services, so the defibrillators market players make informed decisions on the sales of their offerings
- Competitive scenario of various market segments across key countries in several regions for uncovering market opportunities for the stakeholders
- Major players operating in the defibrillators market and their service offerings

In the same way, Stryker Corporation's wholly-owned subsidiary Physio-Control brought the HeartSine samaritan PAD 360P, a fully automatic AED, to the market in April 2017. During an SCA, the device automatically monitors the heart rhythm and sends the electric shock on its own, to stabilize it. In addition, the device also provides protection against water ingress and dust.

Browse report overview with detailed TOC on "Defibrillator Market Research Report - Global Industry Analysis and Growth Forecast to 2030" at: https://www.psmarketresearch.com/market-analysis/defibrillator-market-forecast

Other than product launches, mergers & acquisitions are also being pursued by the players in the defibrillator market, to increase their reach. For example, in August 2019, Cardiac Science Corporation, which manufactures and sells AEDs and offers related services and accessories, was acquired by ZOLL Medical Corporation. This move by ZOLL Medical Corporation was aimed at targeting a wider customer base with a larger AED portfolio.

The major companies operating in the global defibrillator market are Cardiac Science Corporation, SCHILLER AG, ZOLL Medical Corporation, Stryker Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Progetti S.r.l., Mediana Co. Ltd., Boston Scientific Corporation, Abbott Laboratories, Opto Circuits India Ltd., Defibtech LLC, Medtronic plc, MicroPort Scientific Corporation, CU Medical System Inc., Koninklijke Philips N.V., LivaNova PLC, Nihon Kohden Corporation, and BIOTRONIK SE & Co. KG.

The research includes detailed analysis of;

Based on Type
- Implantable Cardioverter Defibrillators (ICDs)
o Transvenous implantable cardioverter defibrillators (T-ICDs)
o Subcutaneous implantable cardioverter defibrillators (S-ICDs)
- External Defibrillators
o Manual defibrillators
o Automated defibrillators (AEDs)

Based on Patient Type
- Adult
- Pediatric

Based on Distribution Channel
- Direct
- Indirect
Based on End User

- Hospitals, Clinics, & Cardiac Centers
- Pre-Hospital Care Settings
- Public Access Settings
- Home Care Settings

Related Report

Genomics Market

North America dominated the global genomics market during the historical period (2014–2019), owing to the several ongoing genomics research projects and high investments being put in to conduct these projects in the region. The U.S. has made a significant contribution to the regional market, through extensive research in the genomics field.

https://www.psmarketresearch.com/market-analysis/genomics-market-revenue

Radiotherapy Market

The global increase in healthcare expenditure is expected to result in upgraded infrastructure, including the installation of advanced medical systems in healthcare settings. Due to these factors, the radiotherapy market is expected to generate $17,194.4 million revenue by 2030, progressing at a CAGR of 8.4% during the forecast period (2020–2030).

https://www.psmarketresearch.com/market-analysis/radiotherapy-market-revenue